Document is current

Any future updates will be listed below

Checkpoint Dilemma: KEYNOTE-564’s Triumph Amidst the Failures of Its Rivals in Renal Cell Carcinoma?

Crossref DOI link: https://doi.org/10.64978/jcrrm-0115

Published Online: 2025-11-06

Update policy: https://doi.org/10.64978/crossmark-policy

About CrossMark